Published in JAMA on September 12, 2006
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (2011) 6.89
Prostanoids in health and disease. J Lipid Res (2008) 2.06
COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA (2006) 1.49
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function. Proc Natl Acad Sci U S A (2009) 1.41
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci (2007) 1.03
Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol (2007) 1.03
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. Cancer Prev Res (Phila) (2009) 0.98
Recognizing the Risks of Chronic Nonsteroidal Anti-Inflammatory Drug Use in Older Adults. Ann Longterm Care (2010) 0.97
New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther (2008) 0.95
Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res (2012) 0.91
4 years after withdrawal of rofecoxib: where do we stand today? Rheumatol Int (2008) 0.90
Nonsteroidal Anti-Inflammatory Drugs and the Kidney. Pharmaceuticals (Basel) (2010) 0.89
Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1. Acta Pharmacol Sin (2010) 0.88
Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium. J Thorac Cardiovasc Surg (2010) 0.85
Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol (2010) 0.85
Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusion. J Cardiovasc Pharmacol (2011) 0.84
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis. Ther Clin Risk Manag (2008) 0.83
Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2016) 0.81
Gleason grading controversies: what the chemoprevention trials have taught us. Can Urol Assoc J (2009) 0.81
Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors. Cost Eff Resour Alloc (2008) 0.81
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species. Oxid Med Cell Longev (2015) 0.80
Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Med Decis Making (2009) 0.80
[DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain]. Z Rheumatol (2016) 0.80
Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies. Eur J Med Chem (2015) 0.79
A new system for profiling drug-induced calcium signal perturbation in human embryonic stem cell-derived cardiomyocytes. J Biomol Screen (2014) 0.78
Patient benefit-risk in arthritis--a rheumatologist's perspective. Rheumatology (Oxford) (2010) 0.78
Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case-Control Cohort Study. Medicine (Baltimore) (2016) 0.78
Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol (2017) 0.77
Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice. PLoS One (2015) 0.77
Celecoxib in arthritis: relative risk management profile and implications for patients. Ther Clin Risk Manag (2009) 0.76
Evaluation of blood pressure and heart rate in patients with hypertension who received tapentadol extended release for chronic pain: a post hoc, pooled data analysis. Clin Drug Investig (2014) 0.76
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals (Basel) (2010) 0.75
Clinical Pharmacology and Cardiovascular Safety of Naproxen. Am J Cardiovasc Drugs (2016) 0.75
Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension. Curr Hypertens Rep (2007) 0.75
Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet. Int J Emerg Med (2010) 0.75
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial. Dig Dis Sci (2007) 0.75
Selective cyclooxygenase-2 inhibitor use and progression of renal function in patients with chronic kidney disease: a single-center retrospective cohort study. Int J Nephrol Renovasc Dis (2016) 0.75
COX-2 inhibitors and hypertension. Curr Hypertens Rep (2007) 0.75
Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis. Core Evid (2007) 0.75
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation. ChemMedChem (2015) 0.75
Review: rofecoxib increases renal events and arrhythmia, but a COX-2-inhibitor class effect does not exist. ACP J Club (2007) 0.75
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials. Onco Targets Ther (2017) 0.75
Analgesic efficacy of celecoxib in patients after oral surgery: special reference to time to onset of analgesia and duration of analgesic effect. Oral Maxillofac Surg (2016) 0.75
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2006) 7.09
Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2009) 5.08
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05
Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) (2008) 4.14
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation (2011) 3.84
Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation (2004) 3.44
Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med (2004) 3.12
Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care (2005) 2.89
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. Am J Epidemiol (2012) 2.20
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care (2006) 2.18
Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes (2006) 2.17
Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity (Silver Spring) (2010) 2.15
Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr (2012) 2.14
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev (2012) 2.13
Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc (2011) 2.10
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med (2007) 2.05
Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr (2010) 2.01
Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis (2009) 2.01
Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke (2004) 1.99
Does perception equal reality? Weight misperception in relation to weight-related attitudes and behaviors among overweight and obese US adults. Int J Behav Nutr Phys Act (2011) 1.94
Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension (2012) 1.85
Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care (2011) 1.65
Dietary intake and dietary quality of low-income adults in the Supplemental Nutrition Assistance Program. Am J Clin Nutr (2012) 1.60
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Corticosteroids reduce postoperative morbidity after third molar surgery: a systematic review and meta-analysis. J Oral Maxillofac Surg (2008) 1.50
Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr (2006) 1.48
Isotemporal substitution paradigm for physical activity epidemiology and weight change. Am J Epidemiol (2009) 1.47
Periodontal health and quality of life in patients with chronic obstructive pulmonary disease. Respir Med (2010) 1.45
Vitamin D levels and menopause-related symptoms. Menopause (2014) 1.41
The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One (2013) 1.40
Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care (2009) 1.37
Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol (2013) 1.31
Dietary intake of whole and refined grain breakfast cereals and weight gain in men. Obes Res (2005) 1.26
Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Diabetes Care (2007) 1.23
Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr (2011) 1.22
Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr (2011) 1.21
Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) (2013) 1.19
Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care (2009) 1.18
Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care (2011) 1.16
Clinical results of carotid artery stenting compared with carotid endarterectomy. J Vasc Surg (2008) 1.15
Alcohol consumption, physical activity, and chronic disease risk factors: a population-based cross-sectional survey. BMC Public Health (2006) 1.14
Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J Nutr (2010) 1.13
Low-income Supplemental Nutrition Assistance Program participation is related to adiposity and metabolic risk factors. Am J Clin Nutr (2011) 1.12
Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr (2010) 1.12
Isotemporal substitution analysis for physical activity, television watching, and risk of depression. Am J Epidemiol (2013) 1.10
Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet (2011) 1.10
The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2010) 1.08
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab (2012) 1.06
A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus. Cancer Res (2011) 1.04
The tau gene haplotype h1 confers a susceptibility to Parkinson's disease. Eur Neurol (2004) 1.04
Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis. PLoS One (2012) 1.03
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care (2008) 1.01
Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes (2010) 1.01
Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol (2012) 1.00
Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort. Clin Chem (2008) 1.00
Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. Am J Epidemiol (2011) 0.99
Prevalence and clustering of metabolic risk factors for type 2 diabetes among Chinese adults in Shanghai, China. BMC Public Health (2010) 0.99
Adiponectin levels and the risk of hypertension: a systematic review and meta-analysis. Hypertension (2013) 0.98
A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. Diabetes (2012) 0.98
Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause (2014) 0.96
Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med (2013) 0.96
Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population. J Lipid Res (2010) 0.96
Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr (2012) 0.93
Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res (2010) 0.93
Racial/ethnic disparities in association between dietary quality and incident diabetes in postmenopausal women in the United States: the Women's Health Initiative 1993-2005. Ethn Health (2013) 0.92
Oral hygiene, periodontal health and chronic obstructive pulmonary disease exacerbations. J Clin Periodontol (2011) 0.92
Sex steroid hormone levels and body composition in men. J Clin Endocrinol Metab (2013) 0.91
Genetic variants in the UCP2-UCP3 gene cluster and risk of diabetes in the Women's Health Initiative Observational Study. Diabetes (2008) 0.91
Evidenced Formal Coverage Index and universal healthcare enactment: A prospective longitudinal study of economic, social, and political predictors of 194 countries. Health Policy (2013) 0.90
Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J Clin Periodontol (2009) 0.90
Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial. J Clin Periodontol (2014) 0.89
Association between periodontitis and chronic obstructive pulmonary disease in a Chinese population. J Periodontol (2012) 0.89
Exposure to the Chinese famine in early life and the risk of hypertension in adulthood. J Hypertens (2011) 0.89
Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, and Asian/Pacific Islander postmenopausal women. Clin Chem (2012) 0.88
Fibrinogen may mediate the association between long sleep duration and coronary heart disease. J Sleep Res (2012) 0.87
A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men. Atherosclerosis (2004) 0.86
Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr (2011) 0.86
Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease. J Am Heart Assoc (2016) 0.86
Serum levels of 25-hydroxyvitamin D, oral health and chronic obstructive pulmonary disease. J Clin Periodontol (2012) 0.85
Comparison of paper- and web-based dietary records: a pilot study. Ann Nutr Metab (2014) 0.85
Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study. Clin Chem (2010) 0.84
Building genetic scores to predict risk of complex diseases in humans: is it possible? Diabetes (2010) 0.83
A novel fatty acid lipophilic index and risk of CHD in US men: the health professionals follow-up study. Br J Nutr (2013) 0.82
Leisure-time physical activity and endometrial cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer (2014) 0.82
Magnesium for cardiovascular health: time for intervention. Am J Clin Nutr (2012) 0.82
Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge. Nutrients (2013) 0.82
Smoking and type 2 diabetes: underrecognized risks and disease burden. JAMA (2007) 0.82